Education
About Us
Working with TipRanks
Follow Us
Epigenomics (DE:ECX)
FRANKFURT:ECX
ECX Stock Chart & Stats
€0.90
-€0.09(-11.17%)
At close: 4:00 PM EDT
€0.90
-€0.09(-11.17%)
Day’s Range― - ―
52-Week Range€0.50 - €1.60
Previous CloseN/A
Volume5.06K
Average Volume (3M)281.00
Market Cap
€789.25K
Enterprise Value€11.36M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.78
Next Earnings
Aug 12, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.23
Shares Outstanding876,949
10 Day Avg. Volume410
30 Day Avg. Volume281
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.00
Price to Sales (P/S)4.66
P/FCF Ratio-0.28
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
ECX FAQ
What was Epigenomics’s price range in the past 12 months?
Epigenomics lowest stock price was €0.50 and its highest was €1.60 in the past 12 months.
What is Epigenomics’s market cap?
Epigenomics’s market cap is €789.25K.
When is Epigenomics’s upcoming earnings report date?
Epigenomics’s upcoming earnings report date is Aug 12, 2026 which is in 208 days.
How were Epigenomics’s earnings last quarter?
Epigenomics released its earnings results on Aug 06, 2025. The company reported -€0.233 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.233.
Is Epigenomics overvalued?
According to Wall Street analysts Epigenomics’s price is currently Overvalued.
Does Epigenomics pay dividends?
Epigenomics does not currently pay dividends.
What is Epigenomics’s EPS estimate?
Epigenomics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Epigenomics have?
Epigenomics has 876,949 shares outstanding.
What happened to Epigenomics’s price movement after its last earnings report?
Epigenomics reported an EPS of -€0.233 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.124%.
Which hedge fund is a major shareholder of Epigenomics?
Currently, no hedge funds are holding shares in DE:ECX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Epigenomics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-1.11%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-78.37%
Trailing 12-Months
Company Description
Epigenomics
Epigenomics AG does not have significant operations. Previously, the company was involved in liquid biopsy for the early detection of cancer. The company was founded in 1998 and is headquartered in Heidelberg, Germany.
Technical Analysis
B.R.A.I.N. Biotechnology Research and Information Network
―
Heidelberg Pharma AG
―
Bio-Gate AG
―
Vitruvia Medical AG
―
―